Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-09-23

Clinical Trial Update: Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update reports the blood pressure lowering efficacy and safety of a treatment regimen combining olmesartan and amlodipine in patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BENICAR (OLMESARTAN MEDOXOMIL)
  • NORVASC (amlodipine besylate)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2009-09-23